Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01208415 · ClinicalTrials.gov registry record · NA
PRESERVE-Zenith® Iliac Branch System Clinical Study
A NA study of Aorto-iliac Aneurysms and Iliac Aneurysms, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 19
- Study locations
NCT01208415 is a NA study of Aorto-iliac Aneurysms and Iliac Aneurysms that has completed, run by Cook Group Incorporated. The registered enrollment target is 40 participants. The trial reports 19 study locations across 13 states.
The verdict
NCT01208415, a NA study of Aorto-iliac Aneurysms and Iliac Aneurysms, has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 19
- Study locations
Study Summary
The PRESERVE-Zenith® Iliac Branch System Clinical Study is a clinical trial to study the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the Zenith® Connection Endovascular Stent/ConnectSX™ covered stent in the treatment of aorto-iliac and iliac aneurysms.
Conditions Studied
Interventions
- DEVICE Endovascular repair for aortoiliac or iliac aneurysms.
Study Locations (19)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Allegheny General Hospital - Pittsburgh
- University of Pittsburgh Medical Center - Pittsburgh
California
- VA Palo Alto HCS - Palo Alto
- Stanford University Medical Center - Stanford
Florida
- Christine E. Lynn Heart and Vascular Institute - Boca Raton
- University of Florida - Gainesville
Missouri
- Washington University School of Medicine - St Louis
- Mercy Hospital East Communities - St Louis
New York
- Columbia University Medical Center - New York
- Weill Cornell Medical Center - New York
Georgia
- Emory University - Atlanta
Massachusetts
- University of Massachusetts - Worcester
Michigan
- William Beaumont Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-01 |
| Est. Completion | 2017-10-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01208415
The ClinicalTrials.gov registry entry for NCT01208415 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Group Incorporated, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Aorto-iliac Aneurysms appearing as the primary indexed condition, and to 1 intervention - of which Endovascular repair for aortoiliac or iliac aneurysms. is the first listed.
NCT01208415 reports 19 study locations spanning 13 distinct geographic areas - top geographies include Pennsylvania, California, Florida.
Frequently Asked Questions
What is clinical trial NCT01208415 about?
NCT01208415 is a clinical study titled "PRESERVE-Zenith® Iliac Branch System Clinical Study". The PRESERVE-Zenith® Iliac Branch System Clinical Study is a clinical trial to study the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the Zenith® Connection Endovascular Stent/ConnectSX™ covered stent in the treatment of aorto-iliac and ilia...
What is the current status of trial NCT01208415?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2011-01. Estimated completion is 2017-10-10.
What conditions does trial NCT01208415 study?
This clinical trial studies the following conditions: Aorto-iliac Aneurysms, Iliac Aneurysms.
What interventions are being tested in trial NCT01208415?
The interventions under investigation include: Endovascular repair for aortoiliac or iliac aneurysms. (DEVICE).
Who is sponsoring clinical trial NCT01208415?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01208415 being conducted?
This trial has 19 study locations across California, Florida, Georgia, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aorto-iliac Aneurysms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.